Both men and women can receive the nine-valent human papillomavirus vaccine, but at present the domestic vaccination of nine-valent is only open to women, and need to be vaccinated three times. Nine-valent vaccine is called nine-valent human papillomavirus vaccine, preventive vaccination is applicable to women aged 16-26 years old, the main effect is to prevent cervical cancer caused by human papillomavirus infection, cervical intraepithelial neoplasia, in addition to the prevention of reproductive system diseases, so China encourages women of age to actively inoculate nine-valent human papillomavirus vaccine. However, both men and women have the same risk of contracting reproductive diseases, and male vaccination with the nine-valent vaccine can also reduce the risk of contracting HPV, especially the risk of penile cancer, condyloma acuminatum and perianal tumors, as well as reduce the probability of contracting the disease to their sexual partners. Therefore, in theory, it is also necessary for men to receive the nine-valent vaccine. At present, the only countries that have approved the vaccine for men are the United States, the United Kingdom, Australia, South Korea and some other countries, and some men in these countries also choose to receive the nine-valent vaccine. The specific method for males to receive the vaccine of the nine-valent vaccine vaccine is the same as that for females, which is also intramuscular injection in the deltoid muscle of the upper arm, and a total of three injections are required.